Spikevax

Medicinal product

(Invented) name

Spikevax

Active substance (s)

COVID-19 iRNR vakcina (modifikuotais nukleozidais). Elasomeranas

Strength

50 µg

Pharmaceutical form

injekcinė dispersija užpildytame švirkšte

Route (s) of administration

leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

J07BN01, covid-19, RNA-based vaccine

Marketing authorisation holder

Moderna Biotech Spain, S.L., Ispanija

Date of authorisation

2021-01-06

Date of renewal

Documents

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Each pre-filled syringe contains 0.5 ml. One dose (0.5 ml) contains:	0.5 ml
COVID-19 iRNR vakcina (modifikuotais nukleozidais). Elasomeranas	50 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
109264	95370	1095370	užpildytas švirkštas	0,5 ml N10		Receptinis	EU/1/20/1507/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-01-06	Registruotas